MenScience Announces Newest Addition to Men's Acne Treatment Line
MenScience, a leading men's skincare, grooming and nutritional supplement company, expands on its line of acne treatment for men with the addition of new Acne Therapy Lotion.
Miami, Florida (PRWEB) October 12, 2007 -- MenScience (www.MenScience.com), a leading men's skincare, grooming and nutritional supplement company, expands on its line of acne treatment for men with the addition of new Acne Therapy Lotion. Formulated with a concentration of 3% Benzoyl Peroxide, Acne Therapy Lotion targets blemishes and reduce acne-causing bacteria on the skin's surface. Benzoyl Peroxide has been used extensively by skincare professionals and dermatologists to treat acne, but because it can often cause redness and dehydration of the skin, Acne Therapy Lotion also contains Green Tea, Allantoin, Panthenol and Urea. Each of these ingredients has been proven to possess moisturizing and water-binding properties, which helps balance irritation caused by Benzoyl Peroxide. This is especially relevant to men's skin care, as a recent MenScience survey concluded that 85 of 100 men polled discontinue use of an acne product if their skin condition appears to redden or worsen after first time usage.
Acne Therapy Lotion marks the second product to be introduced in the new men's acne treatment line, along with the Acne Spot Repair. While Acne Spot Repair is intended for immediate treatment of blemishes (due to the high concentration of 10% Benzoyl Peroxide), once blemishes have been controlled, Acne Therapy Lotion is recommended to prevent future outbreaks and repair acne-stressed skin. Application goes on invisibly and absorbs quickly into the skin. Acne Therapy Lotion is priced at $28.00 and is available, along with the full line of MenScience Androceuticals, at www.MenScience.com or by calling 1-800-608-MENS. MenScience products can also be found at Barneys New York, Nordstrom and premium retailers and spas in the U.S. and worldwide.
###
See the original story at: http://www.prweb.com/releases/2007/10/prweb560176.htm
|
